(Q31924104)

5 July 2017

A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke (English)

1 reference

5 July 2017

Dawson DA

1

1 reference

5 July 2017

Wadsworth G

series ordinal

2

1 reference

5 July 2017

Palmer AM

series ordinal

3

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

5 July 2017

892

1 reference

5 July 2017

2

1 reference

5 July 2017

344-350

1 reference

Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusion

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

A mouse model of focal cerebral ischemia for screening neuroprotective drug effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Lacunar infarcts. Pathogenesis and validity of the clinical syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Massive persistent release of excitatory amino acids following human occlusive stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Clinical trial update: neuroprotection against acute ischaemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Drug development for stroke: importance of protecting cerebral white matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Pathobiology of ischaemic stroke: an integrated view

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-D-aspartate receptor) in patients with acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Mechanisms of ischaemic damage to central white matter axons: a quantitative histological analysis using rat optic nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

The pharmacotherapy of focal cortical ischaemia in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

7 January 2021

Neuroprotective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Ligands of the NMDA receptor-associated glycine recognition site and motor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Cerestat and other NMDA antagonists in ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Does neuroprotection improve stroke outcome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Neuroprotection for acute stroke: making clinical trials work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

The low-affinity, use-dependent NMDA receptor antagonist AR-R 15896AR. An update of progress in stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

N-methyl-D-aspartate antagonists for stroke and head trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Factors determining the therapeutic window for stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2903269-8

10.1016/S0006-8993(00)03269-8

7 January 2021

Identifiers

DOI

1 reference

5 July 2017

1 reference